Valbiotis SA

EPA:ALVAL.PA

1.29 (EUR) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22016 Q12015 Q4
Revenue 0.0350.494.2410.150.6350.150.1482.9710.1210.0450.0460.0790-0.0370.040.1230.1620.1620.162
Cost of Revenue 0.962.0600000000000000.019000
Gross Profit -0.925-1.574.2410.150.6350.150.1482.9710.1210.0450.0460.0790-0.0370.040.1040.1620.1620.162
Gross Profit Ratio -26.429-3.20411111111110110.846111
Reseach & Development Expenses 3.1862.145.0064.5883.7744.2241.9582.9941.5421.4771.7252.5071.3191.3220.3310.4690.3190.1970.197
General & Administrative Expenses 01.2380.9230.8830.7680.5640.5510.7340.6380.6620.6410.7510.4970.5520.270.1270.12300
Selling & Marketing Expenses 01.1430.8730.7920.9110.9670.5420.4780.5450.650.8210.5540.5040.3520.1810.1040.0780.0460.046
SG&A 3.7421.652.0323.2992.3372.3051.6711.6321.3361.4591.4851.4581.0671.0690.4510.2310.201-0.133-0.133
Other Expenses -4.14300-0.023-0.017-0.014-0.056-0.0760.076-0.002000000000
Operating Expenses 2.7853.796.0447.916.1286.5433.6854.7022.8022.9383.213.0611.9021.9960.3740.390.180.0640.064
Operating Income -3.71-5.36-1.802-8.246-5.809-6.885-3.986-2.263-3.151-3.362-3.617-2.874-1.914-2.066-0.335-0.397-0.18-0.143-0.143
Operating Income Ratio -106-10.939-0.425-54.973-9.148-45.9-26.932-0.762-26.041-74.711-78.63-36.38055.838-8.375-3.228-1.115-0.882-0.882
Total Other Income Expenses Net 0.207-0.09-0.118-0.084-0.0650.495-0.0550.443-0.116-0.0330.288-0.15-0.029-0.005-0.0370.001-0.017-0.006-0.006
Income Before Tax -3.503-5.45-1.92-8.33-5.874-6.39-4.041-1.82-3.267-3.395-3.329-3.024-1.943-2.071-0.372-0.396-0.197-0.148-0.148
Income Before Tax Ratio -100.086-11.122-0.453-55.533-9.25-42.6-27.304-0.613-27-75.444-72.37-38.278055.973-9.3-3.22-1.22-0.918-0.918
Income Tax Expense -3.503-0.010.007-1.115-0.777-1.178-0.572-0.922-0.336-0.615-0.605000.0050.0050.0030.0030.0060.006
Net Income -3.503-5.44-1.927-7.215-5.097-5.212-3.469-0.898-2.931-2.78-2.724-3.024-1.943-2.076-0.367-0.399-0.194-0.154-0.154
Net Income Ratio -100.086-11.102-0.454-48.1-8.027-34.747-23.439-0.302-24.223-61.778-59.217-38.278056.108-9.175-3.244-1.201-0.954-0.954
EPS -0.28-0.44-0.16-0.69-0.52-0.54-0.4-0.12-0.41-0.51-0.66-0.77-0.54-1.26-0.1-0.16-0.1-0.043-0.043
EPS Diluted -0.28-0.44-0.16-0.69-0.52-0.54-0.4-0.12-0.41-0.51-0.66-0.77-0.54-1.26-0.1-0.16-0.1-0.043-0.043
EBITDA -3.446-5.155-1.661-7.723-5.392-5.633-3.537-1.138-2.525-2.664-2.78-3.649-2.23-2.009-0.624-0.551-0.011-0.137-0.137
EBITDA Ratio -98.457-10.52-0.392-51.733-8.65-42.62-23.899-0.583-22.157-64.289-68.783-33.848054.297-8.075-4.48-0.068-0.847-0.847